Patented computerized system promises to accelerate cancer trials

The system matches registered patients' own molecular profiles, warehoused in a database of patient-donated biological tissue or tumor samples, to the molecular design of drugs. A new patent has been issued to Moffitt Cancer Center in Tampa, USA for a computerized system that efficiently selects the right patient for the right clinical trial. The system matches registered patients' own molecular profiles—warehoused in a database of thousands of patient-donated biological tissue or tumor samples—to the molecular design of drugs aimed at targeting their disease at the molecular level, and does it quickly. The system promises to accelerate clinical trials and help shorten the time that it takes to get critically needed new drugs into the market. See the full news here.